摘要
抗磷脂综合征(antiphospholipid syndrome,APS)是指抗磷脂抗体(antiphospholipid antibody,APA)阳性并伴有血栓形成或病理妊娠的一组临床征象的总称,可引起早产、流产、先兆子痫、胎儿生长受限等多种不良妊娠结局。2006年公布的《关于APS分类诊断修订标准的国际共识声明》提出了APS的最新诊断标准。妊娠合并APS的治疗包括单独或联合应用免疫抑制剂和抗凝剂、静脉注射免疫球蛋白、血浆交换等。
The antiphospholipid syndrome （AIRS） is defined by the persistent presence of antiphospholipid antibodies in patients with recurrent venous or arterial thromboembolism or pregnancy morbidity. Women with Alas may have diverse pregnancy outcomes, such as preterm delivery, miscarriage, pre - eclampsia and intrauterine growth retardation. In 2006, international consensus statement on an update of the classification criteria for definite APS was addressed, and the newest diagnostic criteria for APS were proposed during the forum. The approaches for women with obstetric manifestations of APS include steroids aspirin, heparins - preferable low molecular weight heparins, immunoglobulins, plasma exchange, etc.
出处
《中国实用妇科与产科杂志》
CAS
CSCD
北大核心
2010年第6期415-417,共3页
Chinese Journal of Practical Gynecology and Obstetrics
关键词
抗磷脂综合征
妊娠
antiphospholipid syndrome
pregnancy
